Recently, Ozempic, Wegovy, and other GLP-1 receptor agonists have become very popular, but their hefty price tags—often over $1,000 a month—make them inaccessible to many people in the U.S. These medications have changed the weight loss field, helping individuals lower their BMI, control blood sugar, and improve heart and kidney health. Over 137 million Americans might be eligible for semaglutide, the main ingredient in Ozempic and Wegovy, and about one in eight U.S. adults have tried a GLP-1 drug.
Despite their potential benefits, obtaining long-term access to drugs like Zepbound, Wegovy, Mounjaro, or Ozempic can be challenging. Some insurance policies cover GLP-1s, and the Biden Administration is looking into broader access for those on Medicare and Medicaid. However, many still face the problem of unaffordable out-of-pocket expenses when their insurance doesn’t cover these drugs.
People are finding ways to get GLP-1s at a lower cost, often through compounded versions. These are generally cheaper but come with risks in terms of safety and effectiveness, especially if purchased from unreliable sources. Consumers are advised to ensure these products come from legitimate, transparent sources with appropriate manufacturing processes in place.
Navigating insurance coverage for GLP-1 medications can be complicated. Some doctors may hesitate to prescribe them for non-diabetic patients due to coverage uncertainties. A common alternative is using compounded versions of these drugs when the FDA permits pharmacies to create them during shortages, though these alternatives are not FDA-approved and could pose quality risks.
Despite these risks, many choose compounded versions due to the effectiveness of ingredients like semaglutide and tirzepatide, but it’s important to consult with a healthcare provider and use an accredited pharmacy. Providers can help manage potential side effects and ensure the correct dosage.
Even if insurance doesn’t cover GLP-1s for obesity treatment, FDA-approved options are still available. For instance, a one-month supply of Wegovy is available for $650 with a Novo Nordisk savings coupon, though this is a limited offer. Eli Lilly offers Zepbound directly to consumers at lower prices, with varying costs depending on the dose.
As of now, a generic version of only one GLP-1 drug is available. Teva started selling a generic form of Victoza, which might be a more affordable choice. However, these costs remain prohibitive for many people.
Buying compounded medications can be risky, especially from unverified sources. Products sold on platforms like TikTok pose unknown risks due to questionable sterility and effectiveness. Taking any medication not prescribed for you is dangerous, particularly for GLP-1s, which come in different dosages. Using someone else’s medication could result in serious health problems. It’s vital to only take medications that a healthcare provider has prescribed specifically for you, considering your medical history, to avoid harmful side effects or interactions.
